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Abstract
Introduction: A pro-apoptotic effect of circulating mediators on renal tubular epithelial cells has been involved in
the pathogenesis of sepsis-associated acute kidney injury (AKI). Adsorption techniques have been showed to
efficiently remove inflammatory cytokines from plasma. The aim of this study was to evaluate the efficiency of the
hydrophobic resin Amberchrom CG161 M to adsorb from septic plasma soluble mediators involved in tubular
injury.
Methods: We enrolled in the study 10 critically ill patients with sepsis-associated AKI and we evaluated the effects
of their plasma on granulocyte adhesion, apoptosis and functional alterations of cultured human kidney tubular
epithelial cells. We established an in vitro model of plasma adsorption and we studied the protective effect of
unselective removal of soluble mediators by the Amberchrom CG161 M resin on septic plasma-induced tubular cell
injury.
Results: Plasma from septic patients induced granulocyte adhesion, apoptosis and altered polarity in tubular cells.
Plasma adsorption significantly decreased these effects and abated the concentrations of several soluble mediators.
The inhibition of granulocyte adhesion to tubular cells was associated with the down-regulation of ICAM-1 and
CD40. Resin adsorption inhibited tubular cell apoptosis induced by septic plasma by down-regulating the
activation of caspase-3, 8, 9 and of Fas/death receptor-mediated signalling pathways. The alteration of cell polarity,
morphogenesis, protein reabsorption and the down-regulation of the tight junction molecule ZO-1, of the sodium
transporter NHE3, of the glucose transporter GLUT-2 and of the endocytic receptor megalin all induced by septic
plasma were significantly reduced by resin adsorption.
Conclusions: Septic plasma induced a direct injury of tubular cells by favouring granulocyte adhesion, by inducing
cell apoptosis and by altering cell polarity and function. All these biological effects are related to the presence of
circulating inflammatory mediators that can be efficiently removed by resin adsorption with a consequent
limitation of tubular cell injury.
Introduction
The incidence of acute kidney injury (AKI) has consid-
erably increased during the past few years [1,2]. AKI is a
frequent complication occurring in critically ill patients
with sepsis or septic shock [3-5]. The mechanisms of
sepsis-induced tissue injury are complex and seem to be
related not only to the ischemic response to hypoperfu-
sion, but also to a direct detrimental activity induced by
circulating mediators with both pro- and anti-
inflammatory properties able to interact in a dynamic
manner and to induce multiple organ failure [5,6].
We recently showed that plasma derived from septic
patients with severe burns induced apoptosis and func-
tional alterations of glomerular podocytes and tubular
epithelial cells (TEC) [7]. These data confirmed the
observations coming from different studies showing that
inflammatory cytokines and lipopolysaccharides (LPS)
activated the apoptotic pathways in tubular cells via cas-
pase activation and Fas up-regulation [8-10]. In addition,
in experimental animal models of sepsis, a broad range
of functional alterations of tubular re-absorption such as
sodium, urea and glucose renal transporter dysfunction
* Correspondence: giovanni.camussi@unito.it
1Center for Experimental Medical Research (CeRMS), University of Torino, Via
Santena 5, Torino 10126, Italy
Cantaluppi et al. Critical Care 2010, 14:R4
http://ccforum.com/content/14/1/R4
© 2010 Cantaluppi et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.has been reported in the presence of an inflammatory
microenvironment [11-13]. Taken together, these data
support the hypothesis of a prominent role of circulat-
ing mediators in the pathogenesis of sepsis-related AKI.
Renal replacement therapy (RRT) is an important
therapeutic strategy in patients with AKI. Several studies
suggested that RRT is able to maintain adequate fluid,
electrolyte and acid-base balance but can also favorably
influence the outcome of AKI patients by removing a
broad range of inflammatory substances [14-16]. Various
mechanisms have been proposed for such removal: dif-
fusion, convection and adsorption [17]. Indeed, the
adsorption matrixes may be useful tools to remove dif-
ferent inflammatory mediators by non-selective simulta-
neous adsorption [18,19]. Based on previous studies,
Amberchrom CG161 M, a rigid, highly cross-linked
microreticular hydrophobic adsorbent polymer was
chosen as having the most convenient particle and pore
size [20].
The aim of this study was to establish an in vitro
model of tubular injury based on the effects of septic
plasma and to evaluate whether the unselective removal
of circulating plasma factors by the Amberchrom resin
could be protective on septic plasma-induced tubular
cell injury.
Materials and methods
Patients
From June to December 2008, 10 critically ill patients
(mean age: 63.9 ± 11.2 years; gender: seven males, three
females) admitted to the intensive care unit (ICU) of the
San Bortolo Hospital in Vicenza, Italy, were enrolled in
the study. Inclusion criteria were: the presence of septic
shock in accordance to the criteria defined by the Amer-
ican College of Chest Physicians and by the Society of
Critical Care Medicine [21]; and the presence of AKI
determined by the evaluation of serum creatinine or
urinary output (inclusion in the failure group of RIFLE
criteria) [22,23]. Exclusion criteria were: age younger
than 18 years, solid organ or bone marrow transplanta-
tion, hemorrhagic dysfunction, thrombophilia, chronic
renal failure, glomerulonephritis or collagenopathies.
The severity of illness was assessed by Sequential Organ
Failure Assessment (SOFA) score at the moment of ICU
admission and at the start of the dialytic treatment. As
control, plasma was obtained from five healthy volun-
teers. Informed consent was obtained according to the
Declaration of Helsinki and the study was authorized by
the Internal Review Board of the San Bortolo Hospital.
In vitro plasma adsorption: experimental design
The Amberchrom CG161 M resin (Rohm and Haas
Company, Philadelphia, PA, USA). was activated in 50%
methanol and extensively washed in isotonic saline. Two
ml of the resin were packed into chromatography col-
umns with an inner diameter of 1 cm (Biorad, Hercules,
CA, USA). Prior to filling with the resin, columns were
treated with silane (Sigma, St. Louis, MO, USA). The
resin beds were perfused with a solution of 4% human
serum albumin in PBS containing a cocktail of recombi-
nant cytokines at the following concentrations (pg/ml):
TNF-a (600), IL-1b (200), IL-10 (350), IL-8 (400), and
IL-6 (300). For IL-1b, an additional series of experi-
ments was carried out using 1 ml of adsorbent and an
IL-1b spike concentration of 300 pg/ml. The flow rate
was set to 0.3 ml/min corresponding to a linear velocity
of 22 cm/h. Fractions of 2 ml were collected and stored
at -80°C until assayed (see below). Before in vitro tests
on tubular cells, the Amberchrom CG161 M resin was
extensively washed by isotonic saline and then mixed
with plasma collected from patients with sepsis-related
AKI (90% volume plasma + 10% volume Amberchrom
CG161 M resin). Plasma/resin mixture was kept in a
condition of slight agitation at 37°C for 120 minutes.
Samples were taken in sterile conditions after 15, 30, 60
and 120 minutes of agitation. At the start and at the
end of adsorption, plasmatic levels of TNF-a,F a s -
Ligand (Fas-L) and CD40-Ligand (CD40-L or CD154)
were determined by ELISA (R&D Systems, Minneapolis,
MN, USA). Results were calculated after generation of a
standard curve with appropriate controls and given as
averages ± standard deviation (SD).
Isolation and characterization of human proximal tubular
epithelial cells and umbilical vein endothelial cells
Primary cultures of human proximal TEC were obtained
from kidneys removed by surgical procedures from
patients affected by renal carcinomas as previously
described [24]. Primary TEC were immortalized by
infection with a hybrid Adeno5/SV40 virus [25] and cul-
tured with RPMI 1640 (GIBCO, Grand Island, NY,
USA) containing 10% FCS (Hyclone, Logan, UT, USA)
and 2 mM glutamine (GIBCO, Grand Island, NY, USA).
The purity of TEC cultures was assessed on the basis of
cell characterization, according to published criteria
[24,25]. Human umbilical vein endothelial cells
(HUVEC) were isolated and characterized as previously
described [26].
Adhesion of polymorphonuclear neutrophils to TEC or
HUVEC monolayers
Polymorphonuclear neutrophils (PMN) were isolated
from blood of healthy volunteers by density centrifuga-
tion as previously described [27] and labeled overnight
with 10 μM Vybrant Cell Tracer kit (Invitrogen, San
Diego, CA, USA) according to the manufacturer’s
instructions in RPMI and 10% FBS. Labeled cells were
counted, resuspended to 50 × 10
6/ml RPMI and added
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on six-well plates and previously incubated with differ-
ent plasma samples. Experiments were carried out in tri-
plicate for one hour at 37°C in conditions of slight
agitation. At the end of incubation, plates were filled
with medium and aspirated three times to remove
unbound cells. All samples were fixed with 1% parafor-
maldehyde and observed under a UV light microscope.
Green fluorescent cells were counted on 10 different
fields at ×100 magnification.
Cytotoxicity assay
TEC were cultured on 24-well plates (Falcon Labware,
Oxnard, CA, USA) at a concentration of 5 × 10
4 cells/
well and incubated with different plasma concentrations
and 250 μg/ml XTT (Sigma, St. Louis, MO, USA) in a
medium lacking phenol red. The absorption values at
4 5 0n mw e r em e a s u r e di na na u t o m a t e ds p e c t r o p h o t -
ometer at different time points. All experiments were
performed in triplicate.
Detection of apoptosis
TUNEL assay
TEC were incubated with different plasma and then
subjected to terminal deoxynucleotidyltransferase-
mediated dUTP nick end labelling (TUNEL) assay
(ApopTag, Oncor, Gaithersburg, MD, USA) that identi-
fies DNA fragmentation, a typical feature of apoptotic
cells. Green-stained apoptotic cells were counted in dif-
ferent microscopic fields at ×100 magnification. In
selected experiments, LPS (30 ng/ml) (Sigma, St. Louis,
MO, USA), polymyxin B (5 μg/ml) (Sigma, St. Louis,
MO, USA), TNF-a (20 ng/ml) (Sigma, St. Louis, MO,
USA) and interferon (IFN)-g (20 ng/ml) (Sigma, St.
Louis, MO, USA) were used.
Propidium iodide nuclear staining
Propidium iodide nuclear staining was used to identify
DNA fragmentation, a typical feature of apoptotic cells.
TEC were cytospinned, fixed with 1% paraformaldehyde
and stained by a solution containing 50 μg/ml propidum
iodide (Sigma, St. Louis, MO, USA), 0.1% sodium citrate
(Sigma, St. Louis, MO, USA), 0.1% Triton-X-100
(Sigma, St. Louis, MO, USA) and 20 μg/ml DNase-free
RNase (Sigma, St. Louis, MO, USA) diluted in sterile
water. All samples were examined by UV light
microscopy.
Generation of transfectants and RNA interference
Chinese hamster ovary (CHO) transfectants were gener-
ated by electroporation with plasmid vectors containing
cDNA coding for a soluble form of Fas-L, CD40-L
(gp39-CD8) or with control empty vectors (mock) at
250 V and 960 μF in 4 mm electroporation cuvettes in
an electroporator II (Invitrogen, San Diego, CA, USA).
Clones were selected for 1 mg/ml G418 resistance in
RPMI 1640 plus 10% FCS. After selection, supernatants
were collected and used for in vitro tests on TEC.
In selected experiments TEC were seeded on six-well
plates and TNF-receptor (R) 1, Fas, CD40 siRNA or
relative control siRNA (80 pM) was introduced accord-
ing to manufacturer’s instructions (Santa Cruz Biotech,
Santa Cruz, CA, USA). After 48 hours, the effective
suppression of specific mRNAs and proteins was veri-
fied by RT-PCR and by immunofluorescence or wes-
tern blot analysis. Subsequently, engineered cells were
used to evaluate plasma-induced apoptosis and PMN
adhesion.
Caspases-3, -8 and -9 activity
T h ea c t i v i t yo fc a s p a s e - 3 ,- 8a n d- 9w a sa s s e s s e db ya
colorimetric assay (Chemicon Int., Temecula, CA, USA)
based on the spectrophotometric detection of the cro-
mophore p-nitroanilide (pNA) after cleavage from the
labelled substrate DEVD-pNA by caspases [24]. Each
experiment was performed in triplicate. Results are
given as average of percentage increase of caspase activ-
ity in respect to incubation with control healthy plasma
± SD.
Analysis of transepithelial electrical resistance
Transepithelial electrical resistance (TER) was used as
an indicator of TEC polarity. Cells were plated in trans-
wells on collagen-coated polycarbonate membranes
(Corning Costar Corp., Cambridge, MA, USA) and
allowed to reach confluence before the addition of dif-
ferent plasma samples. An epithelial volt-ohm meter
(EVOM; World Precision Instruments, Inc., Sarasota,
FL, USA) was used to determine TER values as pre-
viously described [24]. All measures were performed in
triplicate and normalized for the area of the membrane.
Tubular adhesion to extracellular matrixes and
morphogenesis assay
Adhesion of TEC to extracellular matrixes was evaluated
on 24-well culture plates previously coated for six hours
with 20 μg/ml of human fibronectin/type IV collagen or
Matrigel (Becton Dickinson, Franklin Lakes, NJ, USA).
Non-specific adhesion was blocked by incubation for
two hours with 2% BSA diluted in one times PBS. TEC
were exposed to different plasma for six hours at 37°C
in conditions of slight agitation. Thereafter, aliquots of
stimulated cells were added to the wells and allowed to
adhere for two hours at 37°C. Supernatants were then
removed and attached cells were subjected to the XTT-
based assay as reported above. For morphogenesis stu-
dies, TEC were cultured on Matrigel-coated plates for
72 hours and in the presence of control healthy or sep-
tic plasmas.
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Albumin uptake was studied after incubation of TEC
previously exposed to different plasma with 50 mg/ml of
FITC-conjugated human albumin (Sigma, St. Louis,
M O ,U S A )a t3 7 ° Cf o rt w oh o u r s .A f t e rF I T C - a l b u m i n
challenge, TEC were extensively washed twice with ice-
cold one times PBS and analysed by FACS and confocal
microscopy after co-staining with an antibody directed
to megalin (see below).
Immunofluorescence studies
After appropriate stimuli, cultured TEC were fixed in
ethanol/acetic acid 2:1 and stained with antibodies
directed to human Fas (Upstate Biotechnology, Lake
Placid, NY, USA), zonula occludens-1 (ZO-1), megalin,
proximal tubular sodium transporter sodium-hydrogen
exchanger-3 (NHE3) and glucose transporter 2 (GLUT-
2; Santa Cruz Biotech, Santa Cruz, CA, USA). After
incubation with primary antibodies, samples were
washed with one times PBS and incubated with appro-
priated Alexa Fluor-conjugated secondary antibodies
(Molecular Probes, Carlsbad, CA, USA) for 30 minutes,
room temperature when needed. All samples were coun-
terstained by 1 μg/ml propidium iodide or 0.5 μg/ml
Hoechst for 30 seconds, mounted with anti-fade mount-
ing medium (Vector Laboratories, Burlingame, CA,
USA) and examined by confocal microscopy.
FACS analysis
For FACS analysis, after exposure to different plasmas,
TEC were detached from tissue culture plates with
EDTA, washed twice with one times PBS and stained
for one hour at 4°C with FITC-conjugated antibodies
directed to human Fas, CD40, inter-cellular adhesion
molecule-1 (ICAM-1) (Becton Dickinson, Franklin
Lakes, NJ, USA) or with an irrelevant control antibody.
All incubation periods were performed using a medium
containing 0.25% BSA and 0.0016% sodium azide. At
the end of staining, cells were newly washed, fixed in 1%
paraformaldehyde and subjected to FACS analysis (Bec-
ton Dickinson, Franklin Lakes, NJ, USA).
Statistical analysis
All data of different experimental procedures are
expressed as average ± SD. Statistical analysis was per-
formed by analysis of variance with Newmann-Keuls
multicomparison test or Student’s t-test where appro-
priated. The P values less than 0.05 were considered as
the threshold for significance.
Results
Patients
Selected patients with sepsis-associated AKI showed an
average SOFA score of 13.4 ± 7.1 at the start of the
dialytic treatment. AKI was detected by the rise of
serum creatinine (3.3 ± 1.6 mg/dl) and urea (146 ± 84.7
mg/dl). All patients were included in the failure group
of RIFLE criteria [23].
Effect of plasma adsorption on PMN-TEC and PMN-
HUVEC interaction
Septic plasma induced an increased expression of the
costimulatory molecule CD40 and of the adhesion
receptor ICAM-1 on TEC surface (Figure 1a), molecules
that are both deeply involved in the PMN-TEC interac-
tion [28]. Septic plasma induced a significant increase of
PMN adhesion to TEC and to HUVEC in comparison
to healthy plasma (Figures 1b and 1c). Plasma adsorp-
tion with Amberchrom resin significantly inhibited
PMN adhesion on both cell types (Figures 1b and 1c).
The decreased expression of ICAM-1 and in particular
of CD40 on TEC could account for the reduced PMN
adhesion. Indeed, pre-adsorption of septic plasma with
Amberchrom resin inhibited the increased TEC expres-
sion of CD40 and ICAM-1 (Figure 1a). Moreover, PMN
adhesion was increased after incubation of TEC with
supernatants of CHO cells transfected with a cDNA
coding for a soluble form of CD154 (CD40L), but not
with an empty vector (Figure 1d). In addition, a signifi-
cant decrease of septic plasma-induced PMN adhesion
was observed when TEC were transfected by CD40
siRNA but not by control siRNA (Figure 1d).
Effect of plasma adsorption on TEC apoptosis and
cytokine levels
Increasing concentrations of plasma derived from
patients with sepsis-related AKI induced a significant
cytotoxic effect on cultured TEC, as detected by the
XTT-based assay after 48 hours incubation (Figure 2a).
The cytotoxic effect was absent when TEC were cultured
with plasma of healthy volunteers. Septic plasma-induced
TEC toxicity was detected after 12 hours incubation and
remained significantly higher after 24 and 48 hours with
an average 50 to 60% decrease of TEC viability (Figure
2b). In contrast, incubation of TEC with plasma obtained
after Amberchrom resin adsorption showed a significant
reduction of their cytotoxic activity on TEC at all time
points considered (Figure 2b). The cytotoxic effect
exerted by septic plasma on TEC was ascribed to the
apoptotic cascade pathway. Indeed, as showed by TUNEL
assay, exposure of TEC for 48 hours to septic plasma
induced a significant increase of apoptosis in respect to
healthy plasma (Figure 3a). However, when TEC were
cultured for 48 hours in the presence of Amberchrom
resin-adsorbed plasma, the apoptotic rate was signifi-
cantly reduced (Figure 3a). The inhibition of plasma-
induced apoptosis was observed after incubation of TEC
with samples obtained after 15, 30, 60 and 120 minutes
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tion of plasma-induced apoptosis of TEC was detected
with samples obtained after 120 minute adsorption (Fig-
ure 3a). LPS (30 ng/ml) was used as a positive control
(Figure 3a). Interestingly, the addition in culture of 5 μg/
ml polymyxin B significantly reduced but did not com-
pletely abolish the pro-apoptotic activity of septic plasma
(Figure 3a). These results were confirmed by counting
nuclear fragmentation, a typical feature of apoptotic cells,
after propidium iodide staining (not shown). Moreover,
the pre-incubation with septic plasma induced a signifi-
cant increase of TEC apoptosis in the presence of LPS
and inflammatory cytokines (Figure 3b). This effect was
not observed with plasma previously subjected to resin
adsorption or with healthy plasma (Figure 3b). In accor-
dance to the TUNEL data, the activities of caspases-3, -8
and -9 were significantly increased in TEC incubated
with septic plasma. In contrast, a significant reduction of
all caspase activities was observed in TEC cultured in the
presence of Amberchrom resin-treated plasma (120 min-
utes of treatment; Figure 3c). These results suggest that
plasma-induced TEC apoptosis was predominantly asso-
ciated to the activation of the death-receptor pathway
induced by soluble mediators. Indeed, the knock-down of
TNF-R1, Fas and CD40 in TEC by specific siRNA signifi-
cantly decreased the pro-apoptotic activity of septic
plasma (Figure 4a). We also found that supernatants col-
lected from CHO cells transfected with human Fas-L
cDNA induced a significant increase of septic plasma-
associated apoptosis (Figure 4b). The apoptotic rate of
plasma-treated TEC was not affected by supernatants
derived from mock-transfected CHO cells (Figure 4b).
T h e s ed a t as u g g e s tt h a ts e p t i cp l a s m ai n d u c e das e n s i t i -
zation of TEC to Fas-mediated apoptosis. Amberchrom
Figure 1 Evaluation of adhesion molecule expression by TEC and binding of PMN to TEC and HUVEC. (a) FACS analysis of CD40 and
inter-cellular adhesion molecule-1 (ICAM-1) expression by tubular epithelial cells (TEC) incubated with healthy plasma, septic plasma or septic
plasma after Amberchrom resin adsorption (Septic + CG161 M). Kolomogorov Smirnov statistical analysis was performed. (b and c) In vitro
adhesion assay of freshly purified polymorphonuclear neutrophils (PMN) on (b) TEC or (c) human umbilical vein endothelial cells (HUVEC)
monolayers: Amberchrom resin adsorption significantly reduced septic plasma-induced PMN-TEC and PMN-HUVEC interaction (*P < 0.05 Septic
vs Healthy;
§P < 0.05 Septic + CG161 M vs. Septic). (d) Effect of the CD40/CD154 pathway on PMN/TEC interaction: PMN adhesion was
significantly increased in presence of supernatants collected from chinese hamster ovary (CHO) cells transfected with a cDNA coding for a
soluble form of CD154 but not with an empty vector (*P < 0.05 CHO gp39-CD8 vs. Vehicle or CHO mock) and decreased in TEC engineered by
siRNA to knock-down CD40 (
§P < 0.05 Septic + CD40 siRNA vs Septic or Septic + control siRNA). Data in b and c are expressed as average
number ± standard deviation fluorescent cells in 10 different fields (×100 magnification). Analysis of variance with Newmann-Keuls
multicomparison test was performed.
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Fas-mediated apoptosis (Figure 4b). The sensitization of
TEC to Fas-mediated apoptosis may be ascribed to the
up-regulation of Fas on TEC surface induced by septic
plasma that was not observed after Amberchrom resin
adsorption (Figures 4c and 4d). In addition, Amberchrom
resin adsorption reduced the concentration of pro-apop-
totic soluble plasma factors. The high binding capacity of
the Amberchrom resin for different inflammatory cyto-
kines was first evaluated in dynamic tests (Table 1). The
binding activity of the Amberchrom resin was confirmed
by ELISA data on patients’ plasma (Figure 5). At study
admission, septic patients presented high plasmatic levels
of TNF-a, soluble Fas-L and soluble CD40-Ligand
(CD154). After 120 minutes absorption by Amberchrom
resin, all tested cytokines significantly decreased
(Figure 5).
Effect of resin adsorption on functional TEC alterations
Septic plasma significantly reduced TER, an indicator of
TEC polarity. This effect was abrogated in the presence
of Amberchrom resin-treated plasma (Figure 6a).
Further evidence for the maintenance of TEC polarity
and function came from the observation that Amber-
chrom resin abrogated the down-regulation of the tight
junction protein ZO-1, proximal tubular cell sodium
transporter NHE3 and glucose transporter GLUT-2,
w h i c hw e r ea l li n d u c e db ys e p t i cp l a s m a( F i g u r e6 b ) .I n
addition, the reduced adhesion of TEC to the extracellu-
lar matrixes fibronectin/type IV collagen and Matrigel
Figure 2 Protective effect of Amberchrom resin adsorption on septic plasma-induced TEC cytotoxicity. (a) Evaluation of cytotoxicity (XTT-
based assay) after incubation of tubular epithelial cells (TEC) for 48 hours with increasing doses of septic plasma diluted in normal culture
medium (RPMI 1640). Doses of 1% or more induced a significant decrease of TEC viability (*P < 0.05 Septic 1%, 2.5%, 5%, 10% and 20% vs
Healthy plasma). (b) Time-course analysis of TEC cytotoxicity (XTT-based assay) induced by 5% septic plasma before and after Amberchrom resin
adsorption. TEC treated with pre-adsorbed plasma showed a significant increase of hours at all time points considered (*P < 0.05 Septic + CG161
M vs. Septic at 12, 24 and 48 hours). Data are expressed as average O.D. intensity ± standard deviation. Analysis of variance with Newmann-Keuls
multicomparison test was performed.
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cantly inhibited after Amberchrom resin adsorption
(Figure 7a). TEC cultured on Matrigel-coated plates
showed a typical morphology characterized by early
scattering and branching morphogenesis that was
reduced after incubation with septic plasma (Figure 7b).
In contrast, TEC morphogenesis was not affected by
incubation with Amberchrom-adsorbed plasma (Figure
7b). Moreover, we found that septic plasma induced the
down-regulation of the endocytic receptor megalin, a
molecule involved in tubular re-adsorption of filtered
proteins (Figure 8). The decreased expression of megalin
was not observed in the presence of Amberchrom resin-
treated plasma (Figure 8). This phenomenon was prob-
ably responsible for the preserved ability of TEC to
internalize FITC-labeled albumin (Figure 8).
Discussion
The results of the present study showed that septic
plasma induced TEC injury, which was abrogated by
Figure 3 Significant decrease of septic plasma-induced TEC apoptosis and caspase activation after Amberchrom resin adsorption. (a)
Evaluation of tubular epithelial cells (TEC) apoptosis (TUNEL assay) induced by incubation for 48 hours with septic plasma before and after
(septic + CG161 M) Amberchrom resin adsorption for 15, 30, 60 or 120 minutes. Septic plasma induced a marked increase of TEC apoptosis (*P <
0.05 Septic vs Healthy) that was significantly reduced in presence of plasma subjected to resin adsorption at all times points considered (
§P <
0.05 Septic + CG161 M 15, 30, 60 or 120 minutes vs. Septic). Pre-incubation of septic plasma with 5 μg/ml polymyxin B significantly reduced but
not completely abrogated their pro-apoptotic effect on TEC (
§P < 0.05 Septic + polymyxin B vs Septic). Lipopolysaccharide (LPS; 20 ng/ml) was
used as experimental control. Data are expressed as average number of green fluorescent apoptotic cells ± standard deviation in 10 different
fields (×100 magnification). Analysis of variance with Newmann-Keuls multicomparison test was performed. (b) Evaluation of TEC apoptosis
(TUNEL assay) induced by LPS (30 ng/ml) and inflammatory cytokines (TNF-a 20 ng/ml, IFN-g 20 ng/ml) after pre-incubation with different
plasma. Pre-incubation with septic plasma but not with healthy plasma induced an additive effect on LPS/cytokine-induced TEC apoptosis (*P <
0.05 Septic vs Healthy). This effect was significantly decreased after resin adsorption (
§P < 0.05 Septic + CG161M vs. Septic). (c) ELISA evaluation
of caspase-3, -8 and -9 activities in TEC incubated for 48 hours with control healthy plasma or septic plasma before and after (Septic + CG161M)
Amberchrom resin adsorption for 120 minutes. Septic plasma induced a significant increase of all caspase activities (*P < 0.05 caspase-3, -8 and
-9 Septic vs. Healthy), whereas Amberchrom resin adsorption significantly reduced plasma-induced caspase activation (
§P < 0.05 caspase-3, -8
and -9 Septic + CG161M vs Septic). Results are given as % increase of caspase activities in comparison to unstimulated TEC.
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Page 7 of 14Figure 4 Protective effect of resin adsorption on septic plasma-induced sensitisation of TEC to death receptor-mediated apoptosis. (a)
Evaluation of apoptosis (TUNEL assay) induced by incubation for 48 hours with septic plasma on tubular epithelial cells (TEC) transfected with
specific siRNA to knock-down TNFR1, Fas or CD40 expression. The rate of apoptosis was significantly decreased in TEC transfected with all tested
siRNA (*P < 0.05 Septic TNFR1 siRNA, Septic Fas siRNA or Septic CD40 siRNA vs. Septic or Septic control siRNA). (b) Sensitization of TEC to
plasma-induced apoptosis (TUNEL assay) after incubation with supernatants collected from chinese hamster ovary (CHO) cells transfected with a
cDNA coding for a soluble form of Fas Ligand (CHO Fas-L) but not with an empty vector (CHO mock) (*P < 0.05 Septic + CHO FasL vs. Septic or
Septic + CHO mock). CHO cell supernatants did not influence the apoptotic rate of TEC in presence of plasma pre-adsorbed with the
Amberchrom resin. In a and b, data are expressed as average number of green fluorescent apoptotic cells ± standard deviation in 10 different
fields (×100 magnification). Analysis of variance with Newmann-Keuls multicomparison test was performed. (c and d) Representative
immunofluorescence micrographs (c) and FACS analysis (d) of Fas expression in TEC incubated with healthy plasma or septic plasma before and
after (Septic + CG161 M) Amberchrom resin adsorption. In c, nuclei were counterstained by 1 μg/ml propidium iodide (×200 magnification). In d,
Kolomogorov Smirnov statistical analysis was performed.
Table 1 In vitro dynamic test of cytokine adsorption by Amberchrom CG161 M resin
Cytokine Concentration (pg/ml) Amount bound (% leakage)
(pg/ml adsorbent)
Theoretical binding capacity
(pg/ml adsorbent)
TNF-a 675 ± 72 4999 (5%) ± 1703 200,980 ± 53,607
IL-1-b 331 ± 1 61,439 (5%) ± 10,459 116,842 ± 24,707
IL-6 334 ± 59 35,729 (5%) ± 8149 912,776 ± 200,096
IL-8 340 ± 186 322 (12%) ± 161 48,940 ± 26,089
IL-10 464 ± 143 69,187 (5%) ± 31,112 972,880 ± 61,006
The conditions used for the dynamic studies on Amberchrom CG161 M resin are extensively described in the Materials and Methods. Briefly, the resin columns
were perfused at a low linear velocity (0.30 ml/min). The theoretical binding capacity of the resins for individual cytokines which was calculated by extrapolation
of the increase in cytokine concentration at the column outlet over time only gives a rough estimation of the actual maximal binding capacity.
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responsible for PMN-TEC adhesion and for apoptosis
and altered polarity of TEC.
The mechanisms responsible for AKI in the course of
sepsis are not fully elucidated. It has been hypothesized
that inflammatory factors present in the circulation or
locally produced by resident kidney cells may have an
active role in the pathogenesis of tissue damage
[8,10,29]. Indeed, patients with AKI have elevated plas-
matic levels of inflammatory cytokines and high levels
of IL-6 and IL-8 are associated with an increased risk of
mortality [30,31].
In the present study, septic plasma was adsorbed with
Amberchrom CG161 M, a rigid, hydrophobic, highly
cross-linked microreticular adsorbent polymer. Its high
binding capacity depends on the relatively small pore
structure (median pore size 150 to 200 Å, exclusion limit
70 kDa) and high internal surface area (900 m
2/g). The
mean particle size of this polymer is approximately 75 μm,
Figure 6 Effect of resin adsorption on septic plasma-induced alteration of polarity and expression of TEC transporters. (a) Evaluation of
tubular epithelial cells (TEC) polarity expressed as trans-epithelial electrical resistance (TER). Septic plasma induced a significant decrease of TER
(*P < 0.05 Septic vs. Healthy or Vehicle) that was inhibited by Amberchrom resin adsorption (
§P < 0.05 Septic + CG161 M vs Septic). Data are
expressed as average TER values (ohm/cm
2) ± standard deviation. Results were normalized for the membrane area of transwell used in the test.
Analysis of variance with Newmann-Keuls multicomparison test was performed. (b) Representative immunofluorescence micrographs of the
expression of the tight junction protein zonula occludens-1 (ZO-1), the sodium channel NHE3 and the glucose transporter GLUT-2 in TEC
cultured with control healthy plasma or septic plasma before and after (Septic + CG161 M) Amberchrom resin adsorption. Nuclei were
counterstained by 1 μg/ml propidium iodide (magnification ×200).
Figure 5 Significant decrease of cytokine levels in septic
plasma after Amberchrom resin adsorption. ELISA assay of
soluble CD154, soluble Fas-L and TNF-alpha levels in plasma
collected from septic patients before (dark columns) and after
(white columns) Amberchrom resin adsorption for 120 minutes.
Resin adsorption induced a significant decrease of all cytokines
tested (P < 0.05 *CD154,
§Fas-L or
#TNF-alpha septic + CG161 M vs.
septic). Results are expressed as average ± standard deviation. For
statistical analysis, t-student test was performed.
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Page 9 of 14which is convenient for achieving a balance of diffusional
access and flow [20]. We performed dynamic tests as con-
firmation of the high binding capacity of the Amberchrom
resin for different inflammatory cytokines present simulta-
neously at very high concentrations [20]. Although in this
study we focused on the cytokine adsorption, one may
expect that other proteins can bind to the resin as the
hydrophobic polymer exhibits a non-selective affinity with
respect to proteins depending on the exposure of interact-
ing domains. However, experimental and clinical evidence
has suggested that non-selective removal of molecules in
severe sepsis is beneficial [32,33].
In the very early events of sepsis-induced AKI, the adhe-
sion of PMN to TEC may contribute to the pathogenesis
of tissue injury [34]. This process is mediated by adhesion
molecules such as CD40 and ICAM-1 that are up-regu-
lated by inflammatory cytokines [35,36]. Indeed, ICAM-1-
deficient mice are protected from experimental sepsis-
induced AKI [37]. CD40 also plays a crucial role in the
innate response and its inhibition is related to a decrease
of mortality in experimental septic models [38]. Moreover,
the activation of the CD40/CD154 pathway in TEC
induces a pro-fibrotic and pro-inflammatory state [39,40].
We found that after Amberchrom resin adsorption, septic
plasma lost the capacity to up-regulate ICAM-1 and to
activate the CD40/CD154 pathway on cultured human
TEC. This effect may be ascribed to the removal of soluble
CD154 from septic plasma. In the course of sepsis, acti-
vated platelets and leukocytes may release high amounts
of soluble CD154 from their surface that interacts with the
CD40 expressed by TEC and other target cells [41,42]. In
this setting, the removal of soluble CD154 as well as other
inflammatory mediators by resin adsorption may lead to
the inhibition of PMN adhesion to TEC.
Figure 7 Effect of resin adsorption on septic plasma-induced alteration of adhesion to matrixes and TEC morphogenesis. (a) In vitro
adhesion assay of tubular epithelial cells (TEC) to extracellular matrixes. Septic plasma induced a significant decrease of adhesion of TEC to Type
IV collagen/fibronectin (dark columns) or Matrigel (white columns) (*P < 0.05 Septic vs. Healthy or Vehicle). In contrast, Amberchrom resin
adsorption significantly decreased the inhibitory effect of septic plasma on TEC adhesion to all matrixes tested (
§P < 0.05 Septic + CG161 M vs.
Septic). Data are expressed as average O.D. intensity ± standard deviation. Analysis of variance with Newmann-Keuls multicomparison test was
performed. (b) Representative micrographs of TEC morphogenesis after 48 hours culture on Matrigel-coated plates in presence of control healthy
plasma or septic plasma before and after (septic + CG161 M) Amberchrom resin adsorption.
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Page 10 of 14It has been suggested that apoptosis plays a key role in
the pathogenetic mechanisms of sepsis-related tissue
injury including AKI [5,7,43-45]. However, a systematic
review of the histopathological findings in septic AKI
reported a normal histology in the majority of cases
[46]. As apoptosis is a reversible process and apoptotic
cells are rapidly removed by phagocytic cells it may be
difficult to detect tubular apoptotic cells in the histologi-
cal specimens.
Tubular injury is not the mere result of renal hypoper-
fusion or cortico-medullary redistribution of blood flow
[5,47]. A direct toxic effect of circulating or locally-pro-
duced inflammatory cytokines and LPS has been postu-
lated as the main cause of sepsis-related AKI [7-10]. We
found that TEC apoptosis was induced by incubation
with septic plasma through the activation of Fas and
caspases. These events were all abrogated following
Amberchrom resin adsorption of septic plasma. Indeed,
we observed a significant reduction of TNF-a,s o l u b l e
Fas-L and soluble CD154 in septic plasma after incuba-
tion with the Amberchrom resin. The relevance of
TNF-a, soluble Fas-L and soluble CD154 in inducing
TEC injury was confirmed by the observed decrease of
apoptosis in TEC engineered to knock-down Fas, CD40
or TNF-R1 by specific siRNA. These results suggest that
the unselective removal of circulating inflammatory sub-
s t a n c e sb yA m b e r c h r o mr e s i nm a yb er e s p o n s i b l ef o r
the inhibited activation of the death receptor-mediated
apoptotic pathway in TEC.
With the purpose of evaluating the protective effect of
resin adsorption on the extension of sepsis-associated
AKI after the initial insult, we performed a set of experi-
ments aimed at evaluating the role of a ‘priming activity’
of septic plasma on TEC apoptosis. We found that the
pre-incubation of tubular cells with septic plasma pro-
voked an additional effect on apoptosis induced by LPS
and inflammatory cytokines. This effect was decreased
after adsorption of septic plasma by CG161 M resin.
These results suggest that plasma adsorption may limit
the continued renal injury sustained by these mediators.
Despite their pro-apoptotic effect, inflammatory cyto-
kines are also known to alter actin cytoskeleton distribu-
tion and integrin cell-matrix interaction via an i t r i c
oxide-dependent mechanism [48,49]. These events lead
to the shedding of viable or dead cells into the tubular
lumen, causing a possible obstruction to urine flow and
Figure 8 Effect of resin adsorption on albumin internalization and expression of megalin by TEC. Representative FACS and confocal
microscopy analysis of FITC-albumin uptake (green fluorescence) and megalin expression (red fluorescence) in tubular epithelial cells (TEC)
incubated with control healthy plasma or septic plasma before and after (Septic + CG161 M) Amberchrom resin adsorption. For FACS analysis,
Kolomogorov Smirnov statistical analysis was performed. In merge images, nuclei were counterstained by 0.5 μg/ml Hoechst.
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Page 11 of 14back-leakage of fluid in the interstitial spaces [50] asso-
ciated with alteration of cell polarity, a biological function
of epithelial cells essential to maintain a correct electro-
lyte distribution in distinct fluid-filled compartments
[51]. In experimental models of sepsis, a dysfunction at
tight junction level in different organs has been observed
[52,53]. Indeed, inflammatory cytokines induce tight
junction dysfunction in intestinal, pulmonary and hepatic
epithelial cells, an event probably ascribed to an
increased inducible nitric oxide synthase activity [54-56].
In addition, it has been shown that during severe inflam-
mation renal sodium, chloride, urea and glucose trans-
porters are significantly down-regulated via a cytokine-
dependent mechanism [11-13]. Here we show that
Amberchrom resin adsorption inhibited the septic
plasma-induced decrease of TER and the down-regula-
tion of the tight junction protein ZO-1, sodium channel
NHE3 and glucose transporter GLUT-2. Furthermore,
the loss of TEC polarity was associated to a redistribution
of molecules typically expressed on the apical or basolat-
eral surface [51]. This effect may be responsible for the
decreased adhesion of TEC to extracellular matrixes as
well as for the altered morphogenesis. All these biological
effects were inhibited by treatment of plasma with the
Amberchrom resin, suggesting a protective effect related
not only to the inhibition of TEC apoptosis, but also to
the preservation of cell polarity and function.
Microalbuminuria is a typical finding in septic patients
[57]. Urinary loss of proteins may be related to an
increased permeability of the glomerular filtration bar-
rier [58]. However, injured TEC may contribute to pro-
teinuria through the impairment of reabsorption. In this
setting, megalin is an endocytic receptor involved in the
reabsorption of proteins with different molecular weight,
including albumin [59]. Megalin-deficient mice are char-
acterized by the development of low molecular weight
proteinuria [60]. We found that plasma from septic
patients induced the loss of megalin from TEC and
inhibited FITC-labelled albumin reabsorption. Amber-
chrom resin adsorption prevented the loss of megalin
expression and of albumin uptake by TEC induced by
septic plasma. These results also indicate a possible pro-
tective effect of resin adsorption on the maintenance of
protein uptake by injured TEC.
T h eo c c u r r e n c ea n dr e l e v a n c eo fa p o p t o s i sa n do f
increased tubular permeability in human sepsis-asso-
ciated AKI needs to be further critically evaluated. How-
ever, we may hypothesize that plasma circulating in the
peritubular capillaries may enhance PMN adhesiveness
to endothelial, promote vascular permeability and later
induce a direct injury of tubular cells leading to cell
apoptosis and altered cell polarity and function. It is rea-
sonable to think that these changes occur at a very early
stage after the primary insult.
Conclusions
The results of this study showed that septic plasma
induced different injurious effects on cultured TEC by
favouring PMN adhesion, inducing cell apoptosis and
altering cell polarity and function. All these biological
effects are related to the presence of circulating
inflammatory mediators that can be efficiently
removed by unselective resin adsorption with a conse-
quent limitation of tubular cell injury. Whether non-
selective removal of cytokines may have a protective
or therapeutic role in human sepsis-associated AKI is
an attractive possibility which needs further
investigation.
Key messages
￿ Circulating factors present in plasma of septic
patients induce granulocyte adhesion, apoptosis and
alter polarity in tubular cells, biological events
involved in the pathogenesis of sepsis-associated
AKI.
￿ Resin adsorption inhibits septic plasma-induced
granulocyte adhesion to endothelial and tubular cells
mediated by the adhesion receptor ICAM-1 and by
the costimulatory molecule CD40.
￿ Resin adsorption inhibits the apoptosis of tubular
cells induced by septic plasma which is dependent
on the activation of caspase-3, -8, -9 and of the Fas/
death receptor-mediated signalling pathways.
￿ Resin adsorption inhibits the alteration of tubular
cell polarity, morphogenesis, protein uptake and the
down-regulation of the tight junction molecule ZO-
1, of the sodium transporter NHE3, of the glucose
transporter GLUT-2 and of the endocytic receptor
megalin all induced by septic plasma.
￿ The inhibition of septic plasma induced-tubular
cell injury after resin adsorption is associated with
the decrease of soluble mediators involved in inflam-
mation and apoptosis such as TNF-a, Fas-L and
CD40-L.
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